These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27699005)

  • 1. Calprotectin as a diagnostic tool for inflammatory bowel diseases.
    Chatzikonstantinou M; Konstantopoulos P; Stergiopoulos S; Kontzoglou K; Verikokos C; Perrea D; Dimitroulis D
    Biomed Rep; 2016 Oct; 5(4):403-407. PubMed ID: 27699005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal calprotectin -- a useful tool in the management of inflammatory bowel disease.
    Burri E; Beglinger C
    Swiss Med Wkly; 2012; 142():w13557. PubMed ID: 22481443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fecal Calprotectin in Inflammatory Bowel Disease].
    Lee J
    Korean J Gastroenterol; 2016 May; 67(5):233-7. PubMed ID: 27206433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal calprotectin: a marker of inflammation throughout the intestinal tract.
    Summerton CB; Longlands MG; Wiener K; Shreeve DR
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):841-5. PubMed ID: 12172403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
    Buisson A; Vazeille E; Minet-Quinard R; Goutte M; Bouvier D; Goutorbe F; Pereira B; Barnich N; Bommelaer G
    Aliment Pharmacol Ther; 2016 May; 43(10):1069-79. PubMed ID: 26953251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
    van den Bergh FA; Kolkman JJ; Russel MG; Vlaskamp RT; Vermes I
    Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2360-5. PubMed ID: 14677476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
    Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
    Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of faecal calprotectin as non-invasive marker of intestinal inflammation.
    Costa F; Mumolo MG; Bellini M; Romano MR; Ceccarelli L; Arpe P; Sterpi C; Marchi S; Maltinti G
    Dig Liver Dis; 2003 Sep; 35(9):642-7. PubMed ID: 14563186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
    Oyaert M; Trouvé C; Baert F; De Smet D; Langlois M; Vanpoucke H
    Clin Chem Lab Med; 2014 Mar; 52(3):391-7. PubMed ID: 24114912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
    Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal calprotectin in the diagnosis of inflammatory bowel disease.
    Burri E; Beglinger C
    Biochem Med (Zagreb); 2011; 21(3):245-53. PubMed ID: 22420238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP; McNicholl AG
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases.
    Roszak D; Gałęcka M; Cichy W; Szachta P
    Adv Med Sci; 2015 Sep; 60(2):246-52. PubMed ID: 25989184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease.
    Lamb CA; Mansfield JC
    Frontline Gastroenterol; 2011 Jan; 2(1):13-18. PubMed ID: 23904968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease.
    van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T
    J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.
    Costa F; Mumolo MG; Ceccarelli L; Bellini M; Romano MR; Sterpi C; Ricchiuti A; Marchi S; Bottai M
    Gut; 2005 Mar; 54(3):364-8. PubMed ID: 15710984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can faecal calprotectin predict relapse in inflammatory bowel disease: a mini review.
    Chew TS; Mansfield JC
    Frontline Gastroenterol; 2018 Jan; 9(1):23-28. PubMed ID: 29484157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive investigation of inflammatory bowel disease.
    Tibble JA; Bjarnason I
    World J Gastroenterol; 2001 Aug; 7(4):460-5. PubMed ID: 11819811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin in inflammatory bowel disease.
    Walsham NE; Sherwood RA
    Clin Exp Gastroenterol; 2016; 9():21-9. PubMed ID: 26869808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.